Cite

HARVARD Citation

    Poole, C. et al. (n.d.). PWE-153 Cost Effectiveness Of Rifaximin-a In The Reduction Of Recurrence Of Overt Hepatic Encephalopathy. Gut. pp. A191-A192. [Online]. 
  
Back to record